restructuring – Page 4 – Talk Bio

Actionable Insights Powered by AI

Idorsia Pursues Strategic Licensing Deal for TRYVIO Amid Restructuring Efforts

6 months ago talkbio0Tagged financial strategy, Idorsia, restructuring, Tryvio

Idorsia, TRYVIO, aprocitentan, licensing deal, layoffs, restructuring, financial strategy

Novartis Announces 139 Job Cuts in New Jersey Amid Commercial Refocus

6 months ago talkbio0Tagged commercial refocus, New Jersey, Novartis, restructuring

Novartis, job cuts, New Jersey, commercial refocus, restructuring

Embecta Discontinues Insulin Patch Pump Program Amid Restructuring Efforts

6 months ago talkbio0Tagged Diabetes, Discontinuation (procedure), Embecta, insulin patch, pump (device), restructuring, Technology

Embecta, insulin patch pump, discontinuation, restructuring, layoffs, diabetes technology

Biopharma Companies Continue Layoffs: Novartis, Recursion, and Kronos Reduce Staff Amid Industry Restructuring

6 months ago talkbio0Tagged Biopharma layoffs, cost-cutting measures, Drug Industry, Novartis, Recursion, restructuring

Biopharma layoffs, Novartis restructuring, Recursion, Kronos, pharmaceutical industry, workforce reduction, cost-cutting measures

Lexicon Pharmaceuticals Shifts Focus to Clinical Development Following Zynquista Setbacks

7 months ago talkbio0Tagged (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol, Clinical Development, lexicon, LX9211, LX9851, R&D pipeline, restructuring, United States Food and Drug Administration, Zynquista

Lexicon Pharmaceuticals, Zynquista, FDA, Clinical Development, Restructuring, R&D Pipeline, LX9211, Sotagliflozin, LX9851

Lexicon Pharmaceuticals Shifts Focus to Clinical Development Following FDA Setbacks

7 months ago talkbio0Tagged (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol, Chronic Kidney Diseases, Clinical Development, commercial, lexicon, restructuring, setbacks, Surgical aspects, United States Food and Drug Administration

Lexicon Pharmaceuticals, FDA setbacks, Clinical development focus, Commercial operations elimination, Sotagliflozin, Type 1 diabetes, Chronic kidney disease, Restructuring

Sonata Therapeutics Undergoes Restructuring: CEO Exits, 20 Staff Members Laid Off

7 months ago talkbio0Tagged CEO, departure - ActRelationshipType, Flagship, Pioneering, restructuring, Sonata, Staff

Sonata Therapeutics, Flagship Pioneering, CEO departure, staff layoffs, biotech restructuring

Sensei Biotherapeutics Announces Major Restructuring: 46% Workforce Reduction and Closure of Rockville Research Site

7 months ago talkbio0Tagged Clinical Development, Organization administrative structures, Research Site Closure, restructuring, Sensei Biotherapeutics, SNS-101

Sensei Biotherapeutics, workforce reduction, research site closure, organizational restructuring, SNS-101 clinical development

Gilead Sciences and Kite Pharma Announce Layoffs, Closure of Seattle and Philadelphia Offices

7 months ago talkbio0Tagged Gilead Sciences, Industry, Kite Pharma, Office Closures, Philadelphia, restructuring, Seattle

Gilead Sciences, Kite Pharma, layoffs, office closures, Seattle, Philadelphia, biotech industry, restructuring

Thermo Fisher Announces 160 Layoffs in Massachusetts as Part of Viral Vector Overhaul

7 months ago talkbio0Tagged Biotechnology, Massachusetts (geographic location), restructuring, Thermo Fisher, Viral Vector

Thermo Fisher, layoffs, Massachusetts, viral vector, biotechnology, restructuring